Literature DB >> 16328690

Freehand two-step CT-guided brain tumor biopsy: a fast and effective interventional procedure in selected patients.

Loukas Thanos1, Sofia Mylona, Panagiota Galani, Vasilios Kalioras, Maria Pomoni, Nikolaos Batakis.   

Abstract

PURPOSE: To evaluate the efficacy and safety of CT-guided needle biopsy of brain lesions without a stereotactic device, and to determine the best possible indications for this technique.
METHODS: From February 2001 to February 2004, 20 patients (12 men, 8 women; age 61-82 years) underwent CT-guided brain lesion biopsy. The procedure started with a brain CT scan for lesion localization and for selection of the inlet for needle insertion. The patient was then transported to the operating room where cranioanatrisis was performed. Subsequently, the biopsy was performed under CT guidance using a 14G brain biopsy needle with a blind smooth end and lateral holes. At the end of the biopsy, the field was checked for possible complications with a CT scan.
RESULTS: Histopathologic results were: brain tumor in 16 patients (80%), inflammatory process in 3 (15%), and no conclusive diagnosis in 1 (5%). A repeat of the process was required in 2 patients. A minor complication of local hematoma was found in 1 patient (5%). There were no deaths or other serious complications.
CONCLUSION: CT-guided biopsy is a reliable method for histopathologic diagnosis of brain lesions in selected cases. It is a simple, fast, effective, low-cost procedure with minimal complications, indicated especially for superficial and large tumors.

Entities:  

Mesh:

Year:  2006        PMID: 16328690     DOI: 10.1007/s00270-005-0015-2

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  1 in total

1.  The diagnostic quality of needle brain biopsy specimens obtained with different sampling methods - Experimental study.

Authors:  Piotr Trojanowski; Bożena Jarosz; Dariusz Szczepanek
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.